Amoxicillin Dosing in Pediatric Patients
For most acute bacterial infections in children ≥3 months old, prescribe amoxicillin 45 mg/kg/day divided into 2 doses for mild-to-moderate infections, or 90 mg/kg/day divided into 2 doses for severe infections, high-resistance areas, or children with specific risk factors (maximum 4 g/day). 1
Standard-Dose Regimen (45 mg/kg/day)
Use standard-dose amoxicillin (45 mg/kg/day in 2 divided doses) for:
- Uncomplicated respiratory tract infections in children ≥2 years without recent antibiotic exposure 2, 1
- Community-acquired pneumonia (mild-to-moderate) in outpatient settings 1
- Acute bacterial sinusitis in children ≥2 years who do not attend daycare and have not received antibiotics in the past 4 weeks 2
- Skin and genitourinary infections in children ≥3 months and <40 kg 1
This dosing provides adequate coverage against susceptible Streptococcus pneumoniae, non-β-lactamase-producing Haemophilus influenzae, and Streptococcus pyogenes. 1
High-Dose Regimen (80–90 mg/kg/day)
Prescribe high-dose amoxicillin (80–90 mg/kg/day in 2 divided doses, maximum 4 g/day) when ANY of the following risk factors are present:
- Age <2 years 2, 1
- Daycare attendance 2, 1
- Recent antibiotic use (within past 30 days) 2, 1
- Geographic areas with >10% penicillin-resistant S. pneumoniae 2, 1
- Moderate-to-severe illness at presentation 2
- Incomplete Haemophilus influenzae type b vaccination 1
High-dose therapy achieves sinus and middle-ear fluid concentrations adequate to overcome penicillin-resistant S. pneumoniae (MIC up to 2–4 mg/L). 2, 3
Indication-Specific Dosing
Group A Streptococcal Pharyngitis
- 50–75 mg/kg/day in 2 divided doses for 10 days (maximum 1,000 mg per dose) 1
- Patients become non-contagious after 24 hours of therapy 1
- Therapy may be initiated up to 9 days after symptom onset and still prevent acute rheumatic fever 1
Acute Otitis Media
- Standard dose (45 mg/kg/day): For children ≥2 years without risk factors 4
- High dose (80–90 mg/kg/day): For children <2 years, recent antibiotic exposure, or severe presentation 1, 3
- Treatment duration: 10 days for children <6 years 3
Community-Acquired Pneumonia
- Mild-to-moderate: 45 mg/kg/day in 2 doses 1
- Severe or high-resistance areas: 90 mg/kg/day in 2 doses 1
- Treatment duration: 10 days 1
Acute Bacterial Sinusitis
- Standard dose (45 mg/kg/day): Children ≥2 years without risk factors 2
- High dose (80–90 mg/kg/day): Children <2 years, daycare attendees, or recent antibiotic use 2
- Treatment duration: Continue for 7 days after symptom resolution (minimum 10 days total) 2
When to Use Amoxicillin-Clavulanate Instead
Switch from amoxicillin to amoxicillin-clavulanate (90 mg/kg/day of amoxicillin component + 6.4 mg/kg/day clavulanate in 2 doses) when:
- Treatment failure after 48–72 hours on amoxicillin alone 1, 3
- Recent antibiotic exposure within 4–6 weeks 4, 3
- Suspected β-lactamase-producing organisms (H. influenzae, M. catarrhalis) 2, 1
- Incomplete H. influenzae type b vaccination (<3 doses) 3
- Concurrent purulent acute otitis media with pneumonia 1
The high-dose amoxicillin-clavulanate formulation (14:1 ratio) provides adequate clavulanate levels to inhibit all β-lactamase-producing H. influenzae and M. catarrhalis while minimizing diarrhea compared to other ratios. 2, 3
Treatment Duration by Indication
- Group A streptococcal pharyngitis: 10 days 1
- Acute otitis media: 10 days (children <6 years); 5–7 days may be considered in older children 4, 3
- Community-acquired pneumonia: 10 days 1
- Acute bacterial sinusitis: 7 days after symptom resolution (minimum 10 days) 2
- Most respiratory infections: 7–10 days 1
Monitoring and Expected Response
- Clinical improvement should occur within 48–72 hours of initiating therapy 1, 3
- Fever typically resolves within 24–48 hours for pneumococcal infections, though cough may persist 1
- If no improvement or worsening after 48–72 hours: Reassess diagnosis, consider atypical pathogens, switch to amoxicillin-clavulanate, or add a macrolide 1, 3
Maximum Dosing Limits
- Maximum daily dose: 4,000 mg/day (4 g/day) regardless of weight 1
- Maximum single dose: 2,000 mg per dose 2, 3
- For children ≥40 kg: Dose as adults using standard adult formulations 1
Penicillin-Allergic Patients
- Non-anaphylactic reactions: Second- or third-generation cephalosporins (cefdinir, cefuroxime, cephalexin) are safe alternatives; cross-reactivity risk is negligible 2, 1
- Type I (IgE-mediated) reactions: Use clindamycin (10–20 mg/kg/day in 3 doses) or azithromycin (12 mg/kg once daily for 5 days), though these have inferior efficacy 1, 4
Critical Pitfalls to Avoid
- Do NOT underdose older or heavier children: Prescribers often give subtherapeutic doses to children >20 kg, leading to treatment failure and resistance 5
- Do NOT prescribe antibiotics for viral URTIs: Approximately 70% of pediatric sore throats are viral and require no antibiotics 1
- Do NOT use amoxicillin alone for β-lactamase producers: Use amoxicillin-clavulanate when H. influenzae or M. catarrhalis are suspected 2, 1
- Verify suspension concentration before dispensing: Confusion between 125/31 and 250/62 formulations causes dosing errors 3
- Always document on prescription: Daily dose, number of divided doses, duration, indication, and child's weight 6
Age-Specific Considerations
- Infants <3 months: Amoxicillin safety data are limited; prefer intravenous regimens (ampicillin + gentamicin or cefotaxime) for serious bacterial infections 3
- Children ≥3 months: Amoxicillin is safe and effective for indicated bacterial infections 1, 3
- Children unable to tolerate oral medication: Single dose of ceftriaxone 50 mg/kg IV/IM, then switch to oral therapy after 24 hours if improved 2